Reply to Marakasova and Baranova, "MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection".

Gold, Jeffrey E; Hurley, David J; Rada, Balázs; Baumgartl, William H; Tilley, Larry P; Licht, Warren E

Gold, Jeffrey E; Hurley, David J; Rada, Balázs; Baumgartl, William H; Tilley, Larry P; Licht, Warren E.

Gold JE; World Organization, Watkinsville, Georgia, USA jeff_gold@world.org.
Hurley DJ; College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
Rada B; College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
Baumgartl WH; Nevada Spine Center, Las Vegas, Nevada, USA.
Tilley LP; VetMed Consultants, Inc., Santa Fe, New Mexico, USA.
Licht WE; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

mBio ; 12(1)2021 02 02.

Article in English | MEDLINE | ID: covidwho-1060984

Subject(s)

COVID-19; Measles; Mumps; Rubella; Complement Activation; Humans; Measles/prevention & control; Measles-Mumps-Rubella Vaccine; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rubella / COVID-19 / Measles / Mumps Type of study: Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: MBio.03682-20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google